It is believed that progression under ADT is because of the ability of cancer cells to overcome a low androgen environment through upregulation of enzymes involved in androgen synthesis, producing androgen and stimulating their own growth, or overexpression of the AR or mutations of the AR gene [7]. This evidence concerns the gene AR and cancer.